1. Neuroscience

The heritability of multi-modal connectivity in human brain activity

  1. Giles L Colclough  Is a corresponding author
  2. Stephen M Smith
  3. Tom E Nichols
  4. Anderson M Winkler
  5. Stamatios N Sotiropoulos
  6. Matthew F Glasser
  7. David C Van Essen
  8. Mark W Woolrich
  1. University of Oxford, United Kingdom
  2. University of Warwick, United Kingdom
  3. Washington University, United States
  4. Washington University in St Louis, United States
https://doi.org/10.7554/eLife.20178
Share this article
Cite this article
  1. Giles L Colclough
  2. Stephen M Smith
  3. Tom E Nichols
  4. Anderson M Winkler
  5. Stamatios N Sotiropoulos
  6. Matthew F Glasser
  7. David C Van Essen
  8. Mark W Woolrich
(2017)
The heritability of multi-modal connectivity in human brain activity
eLife 6:e20178.
https://doi.org/10.7554/eLife.20178
  2. Download BibTeX
  3. Download .RIS

Abstract

Patterns of intrinsic human brain activity exhibit a profile of functional connectivity that is associated with behaviour and cognitive performance, and deteriorates with disease. This paper investigates the relative importance of genetic factors and the common environment between twins in determining this functional connectivity profile. Using functional magnetic resonance imaging (fMRI) on 820 subjects from the Human Connectome Project, and magnetoencephalographic (MEG) recordings from a subset, the heritability of connectivity between 39 cortical regions was estimated. On average over all connections, genes account for about 15% of the observed variance in fMRI connectivity (and about 10% in alpha-band and 20% in beta-band oscillatory power synchronisation), which substantially exceeds the contribution from the environment shared between twins. Therefore, insofar as twins share a common upbringing, it appears that genes, rather than the developmental environment, play a dominant role in determining the coupling of neuronal activity.

Data availability

The following previously published data sets were used
    1. Van Essen DC et al.
    (2013) The Human Connectome Project HCP500 data release
    Open access dataset available from ConnectomeDB (https://db.humanconnectome.org/app/template/Login.vm). Account registration is required and access to certain data elements such as family structure is subject to restricted use terms (please see http://www.humanconnectome.org/study/hcp-young-adult/data-use-terms).
    http://www.humanconnectome.org/study/hcp-young-adult/document/900-subjects-data-release
    1. Larson-Prior LJ
    (2013) The Human Connectome Project MEG2 data release
    Open access dataset available from ConnectomeDB (https://db.humanconnectome.org/app/template/Login.vm). Account registration is required and access to certain data elements such as family structure is subject to restricted use terms (please see http://www.humanconnectome.org/study/hcp-young-adult/data-use-terms).
    http://www.humanconnectome.org/study/hcp-young-adult/document/900-subjects-data-release

Article and author information

Author details

  1. Giles L Colclough

    Oxford Centre for Human Brain Activity, University of Oxford, Oxford, United Kingdom
    For correspondence
    giles.colclough@ohba.ox.ac.uk
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1074-7186

  2. Stephen M Smith

    Oxford Centre for Human Brain Activity, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.

  3. Tom E Nichols

    Department of Statistics and WMG, University of Warwick, Coventry, United Kingdom
    Competing interests
    No competing interests declared.

  4. Anderson M Winkler

    Oxford Centre for Human Brain Activity, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.

  5. Stamatios N Sotiropoulos

    Oxford Centre for Human Brain Activity, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.

  6. Matthew F Glasser

    School of Medicine, Washington University, St. Louis, United States
    Competing interests
    No competing interests declared.

  7. David C Van Essen

    School of Medicine, Washington University in St Louis, St. Louis, United States
    Competing interests
    David C Van Essen, Senior editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7044-4721

  8. Mark W Woolrich

    Oxford Centre for Human Brain Activity, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.

Funding

Research Councils UK (Digital Economy Programme (EP/G036861/1,Centre for Doctoral Training in Healthcare Innovation))

  • Giles L Colclough

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq,211534/2013-7)

  • Anderson M Winkler

Engineering and Physical Sciences Research Council (EP/L023067)

  • Stamatios N Sotiropoulos

National Institutes of Health (R01EB015611-01; NRSA fellowship (F30-MH097312); 1U54MH091657)

  • Tom E Nichols
  • Matthew F Glasser
  • David C Van Essen

National Institute for Health Research (NIHR Oxford Biomedical Research Centre)

  • Mark W Woolrich

Medical Research Council (MRC UK MEG Partnership Grant (MR/K005464/1))

  • Giles L Colclough
  • Mark W Woolrich

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: HCP data were acquired using protocols approved by the Washington University institutional review board. Informedconsent was obtained from subjects. Anonymised data are publicly available from ConnectomeDB (db.humanconnectome.org; Hodge et al. (2016)). Certain parts of the dataset used in this study, such as the family structures of the subjects, are available subject to restricted data usage terms, requiring researchers to ensure that the anonymity of subjects is protected (Van Essen et al., 2013).

Copyright

© 2017, Colclough et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 643
    downloads

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

Share this article

https://doi.org/10.7554/eLife.20178

Categories and tags

Research organism

Further reading

    1. Neuroscience

    Rab10 regulates neuropeptide release by maintaining Ca2+ homeostasis and protein synthesis

    Jian Dong, Mian Chen ... Matthijs Verhage
    Research Article

    Dense core vesicles (DCVs) transport and release various neuropeptides and neurotrophins that control diverse brain functions, but the DCV secretory pathway remains poorly understood. Here, we tested a prediction emerging from invertebrate studies about the crucial role of the intracellular trafficking GTPase Rab10, by assessing DCV exocytosis at single-cell resolution upon acute Rab10 depletion in mature mouse hippocampal neurons, to circumvent potential confounding effects of Rab10’s established role in neurite outgrowth. We observed a significant inhibition of DCV exocytosis in Rab10-depleted neurons, whereas synaptic vesicle exocytosis was unaffected. However, rather than a direct involvement in DCV trafficking, this effect was attributed to two ER-dependent processes, ER-regulated intracellular Ca2+ dynamics, and protein synthesis. Gene Ontology analysis of differentially expressed proteins upon Rab10 depletion identified substantial alterations in synaptic and ER/ribosomal proteins, including the Ca2+ pump SERCA2. In addition, ER morphology and dynamics were altered, ER Ca2+ levels were depleted, and Ca2+ homeostasis was impaired in Rab10-depleted neurons. However, Ca2+ entry using a Ca2+ ionophore still triggered less DCV exocytosis. Instead, leucine supplementation, which enhances protein synthesis, largely rescued DCV exocytosis deficiency. We conclude that Rab10 is required for neuropeptide release by maintaining Ca2+ dynamics and regulating protein synthesis. Furthermore, DCV exocytosis appeared more dependent on (acute) protein synthesis than synaptic vesicle exocytosis.

    1. Neuroscience

    Neuronal Signaling: At the crossroads of calcium signaling, protein synthesis and neuropeptide release

    Jakob Rupert, Dragomir Milovanovic
    Insight

    By influencing calcium homeostasis, local protein synthesis and the endoplasmic reticulum, a small protein called Rab10 emerges as a crucial cytoplasmic regulator of neuropeptide secretion.

    1. Neuroscience

    Peripheral opioid receptor antagonism alleviates fentanyl-induced cardiorespiratory depression and is devoid of aversive behavior

    Brian C Ruyle, Sarah Masud ... Jose A Morón
    Research Article

    Millions of Americans suffering from Opioid Use Disorders face a high risk of fatal overdose due to opioid-induced respiratory depression (OIRD). Fentanyl, a powerful synthetic opioid, is a major contributor to the rising rates of overdose deaths. Reversing fentanyl overdoses has proved challenging due to its high potency and the rapid onset of OIRD. We assessed the contributions of central and peripheral mu opioid receptors (MORs) in mediating fentanyl-induced physiological responses. The peripherally restricted MOR antagonist naloxone methiodide (NLXM) both prevented and reversed OIRD to a degree comparable to that of naloxone (NLX), indicating substantial involvement of peripheral MORs to OIRD. Interestingly, NLXM-mediated OIRD reversal did not produce aversive behaviors observed after NLX. We show that neurons in the nucleus of the solitary tract (nTS), the first central synapse of peripheral afferents, exhibit a biphasic activity profile following fentanyl exposure. NLXM pretreatment attenuates this activity, suggesting that these responses are mediated by peripheral MORs. Together, these findings establish a critical role for peripheral MORs, including ascending inputs to the nTS, as sites of dysfunction during OIRD. Furthermore, selective peripheral MOR antagonism could be a promising therapeutic strategy for managing OIRD by sparing CNS-driven acute opioid-associated withdrawal and aversion observed after NLX.